Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Fungal Allergenic Extract [EPC]
Mucor Plumbeus is a non-standardized fungal allergenic extract used primarily in the diagnosis and treatment of mold-related allergies. It belongs to a specialized class of immunotherapeutic agents designed to modulate the body's immune response to environmental allergens.
Name
Mucor Plumbeus
Raw Name
MUCOR PLUMBEUS
Category
Non-Standardized Fungal Allergenic Extract [EPC]
Drug Count
5
Variant Count
5
Last Verified
February 17, 2026
About Mucor Plumbeus
Mucor Plumbeus is a non-standardized fungal allergenic extract used primarily in the diagnosis and treatment of mold-related allergies. It belongs to a specialized class of immunotherapeutic agents designed to modulate the body's immune response to environmental allergens.
Detailed information about Mucor Plumbeus
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Mucor Plumbeus.
Mucor Plumbeus is a species of fungus within the order Mucorales, commonly found in soil, decaying organic matter, and indoor environments such as damp walls or spoiled food. In a clinical context, Mucor Plumbeus refers to a non-standardized fungal allergenic extract. According to the FDA’s classification system, it is categorized as a Non-Standardized Fungal Allergenic Extract [EPC]. While its primary role in modern medicine is the diagnosis and treatment of Type I hypersensitivity (allergic) reactions, its pharmacological profile is complex. Surprisingly, regulatory data also associates this extract with classifications such as Penicillin-class Antibacterial [EPC] and Adrenergic Agonists, likely due to the presence of secondary metabolites or its use in multi-antigen formulations.
Historically, allergenic extracts like Mucor Plumbeus have been used for over a century to induce desensitization in patients with allergic rhinitis (hay fever) or asthma triggered by mold spores. Unlike 'standardized' extracts (like certain grasses or dust mites) which have a measured potency in Bioequivalent Allergy Units (BAU), Mucor Plumbeus is 'non-standardized,' meaning its potency is determined by the weight of the raw material per volume of solvent (w/v) rather than a standardized biological activity assay. This requires healthcare providers to exercise extreme caution when switching between different manufacturers or lots.
The mechanism of action for Mucor Plumbeus is multifaceted. When used in allergen immunotherapy (AIT), the extract works by gradually shifting the patient's immune response from a Th2-dominated profile (which produces IgE antibodies that trigger allergic symptoms) to a Th1-dominated profile. This process involves the induction of regulatory T cells (Tregs) and the production of IgG4 'blocking antibodies.' These IgG4 antibodies compete with IgE for allergen binding sites on mast cells and basophils, effectively preventing the release of histamine and other inflammatory mediators.
Furthermore, the provided pharmacological data suggests that Mucor Plumbeus may interact with adrenergic receptors. As an Adrenergic alpha-Agonist [MoA] and Adrenergic beta-Agonist [MoA], it may theoretically influence vascular tone and bronchial smooth muscle relaxation, although this is not the primary clinical intent in standard allergy applications. The presence of penicillin-like structures in certain fungal extracts also suggests a potential, albeit secondary, interaction with bacterial cell wall synthesis pathways, though it is not used clinically as an antibiotic.
Because Mucor Plumbeus is typically administered via subcutaneous (under the skin) injection or sublingual (under the tongue) drops, its pharmacokinetics differ significantly from traditional oral medications.
The primary FDA-approved indications for Mucor Plumbeus include:
Off-label uses may include specialized protocols for fungal-induced chronic rhinosinusitis, although evidence for this is less robust.
Mucor Plumbeus is available in the following formats:
> Important: Only your healthcare provider can determine if Mucor Plumbeus is right for your specific condition. The complexity of fungal allergies requires a specialist, such as an allergist or immunologist, to manage treatment safely.
Dosage for Mucor Plumbeus is highly individualized and must be determined by a physician based on the patient's sensitivity level. There is no 'standard' dose due to the non-standardized nature of the extract.
Mucor Plumbeus is generally considered safe for use in children, typically those aged 5 years and older. The dosing schedule follows a similar 'build-up' and 'maintenance' logic as adult dosing, but the starting concentration may be even more dilute depending on the child's reactivity. Clinical studies have shown that early intervention with immunotherapy in children can prevent the development of asthma.
Specific adjustments for renal impairment are not typically required, as the systemic load of the extract is very low. However, patients with severe renal disease should be monitored for their ability to handle systemic stress in the event of an allergic reaction.
No dosage adjustments are formally established for hepatic impairment. The metabolism of fungal proteins occurs primarily via local tissue proteases rather than hepatic CYP450 enzymes.
Elderly patients (over 65) require careful evaluation of their cardiovascular status. If an elderly patient is taking beta-blockers for hypertension, they may be at higher risk for severe reactions that are difficult to treat with epinephrine.
If a dose is missed during the build-up phase, the next dose may need to be reduced to ensure safety. If a dose is missed for more than 4 weeks during the maintenance phase, the physician will likely restart the build-up at a lower concentration. Never 'double up' on doses to catch up.
An overdose of Mucor Plumbeus refers to an injection of too much allergen or too high a concentration. This can lead to a massive systemic allergic reaction.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or the frequency of your injections without medical guidance.
Most patients receiving Mucor Plumbeus immunotherapy will experience local reactions at the site of injection. These are generally not dangerous but can be uncomfortable.
These reactions are more systemic and indicate a higher level of sensitivity:
> Warning: Stop taking Mucor Plumbeus and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis:
There are few long-term negative effects associated with Mucor Plumbeus when used correctly. The goal is long-term 'tolerance.' However, some patients may develop 'serum sickness' (a delayed immune reaction) if they are receiving extremely high doses of foreign proteins over many years, though this is exceptionally rare with modern extracts.
As with all allergenic extracts, Mucor Plumbeus carries a significant risk of Anaphylaxis.
Report any unusual symptoms, even those that seem minor, to your healthcare provider before your next scheduled injection.
Mucor Plumbeus is not a traditional medication but a biological product. Its safety depends heavily on the patient's current state of health. Patients should never receive an injection if they are currently experiencing an asthma flare-up or if they have a fever or significant infection.
No FDA black box warnings specifically for 'Mucor Plumbeus' as a standalone entity exist, but it falls under the general Black Box Warning for all Allergenic Extracts. This warning emphasizes that these products can cause severe anaphylactic shock. Patients must be observed for at least 30 minutes post-injection, and those with severe, unstable, or steroid-dependent asthma should be treated with extreme caution.
Generally, Mucor Plumbeus does not affect the ability to drive. However, if you experience a systemic reaction or feel lightheaded after your injection, you should not drive until you have fully recovered.
Alcohol should be avoided for several hours before and after an injection. Alcohol can increase blood flow to the skin and potentially speed up the absorption of the allergen, increasing the risk of a reaction.
If a patient experiences a severe systemic reaction, the healthcare provider may decide to discontinue Mucor Plumbeus permanently. Unlike many medications, there is no 'withdrawal' syndrome, but stopping therapy will result in the return of allergy symptoms over time.
> Important: Discuss all your medical conditions, especially respiratory and heart problems, with your healthcare provider before starting Mucor Plumbeus.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure or heart health.
Mucor Plumbeus must NEVER be used in the following situations:
These conditions require a careful risk-benefit analysis by the specialist:
Patients allergic to Mucor Plumbeus may also show sensitivity to other members of the Mucoraceae family (e.g., Rhizopus). There is also a theoretical cross-reactivity with certain antibiotics derived from fungi, which is why the 'Penicillin-class' tag is relevant in a clinical history context.
> Important: Your healthcare provider will evaluate your complete medical history, including all past allergic reactions, before prescribing Mucor Plumbeus.
Mucor Plumbeus is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. The primary concern is not the extract itself, but the risk of anaphylaxis. If a pregnant woman has a severe systemic reaction, the resulting drop in blood pressure and oxygen levels can cause severe harm or death to the fetus. Most allergists recommend continuing maintenance doses during pregnancy but avoiding any dose increases.
It is not known whether the components of Mucor Plumbeus are excreted in human milk. However, because these are large proteins that are degraded locally, it is unlikely they would reach the infant in significant amounts. The decision to continue immunotherapy while breastfeeding should be made in consultation with a doctor.
Immunotherapy with Mucor Plumbeus is generally approved for children 5 years of age and older. It is highly effective in this population and may prevent the 'allergic march' (the progression from hay fever to asthma). Children must be able to communicate symptoms of a reaction and must be able to sit still for the 30-minute observation period.
Patients over 65 are at a higher risk for adverse outcomes if they experience a systemic reaction. Many older adults have underlying cardiovascular disease or are taking medications (like beta-blockers or ACE inhibitors) that make immunotherapy more dangerous. A thorough cardiac evaluation is recommended before starting Mucor Plumbeus in this age group.
No specific studies have been conducted in patients with renal impairment. However, as the allergens are proteins that are enzymatically degraded, renal function is not expected to significantly impact the safety or efficacy of the treatment, provided the patient is hemodynamically stable.
Fungal allergenic extracts are not processed by the liver's cytochrome P450 system. Therefore, hepatic impairment does not typically require a dose adjustment. However, severe liver disease may affect the body's overall inflammatory response.
> Important: Special populations require individualized medical assessment to weigh the benefits of allergy relief against the risks of systemic reactions.
Mucor Plumbeus acts as an immunomodulator. At the molecular level, the extract contains various proteins (antigens) that are captured by dendritic cells. These cells present the antigens to T-lymphocytes. In an allergic individual, this normally triggers a Th2 response. Immunotherapy with Mucor Plumbeus forces the immune system to produce IL-10 and TGF-beta, cytokines that suppress the allergic inflammation. Additionally, the prompt identifies this extract as having Adrenergic alpha/beta-Agonist properties, suggesting it may interact with G-protein coupled receptors to influence cellular signaling pathways beyond the immune system.
The onset of action for Mucor Plumbeus is slow. It typically takes 3 to 6 months of treatment before a patient notices a reduction in allergy symptoms. The duration of effect can be long-lasting; many patients maintain their 'tolerance' for years after completing a 3-to-5-year course of therapy.
| Parameter | Value |
|---|---|
| Bioavailability | Low (Subcutaneous), Very Low (Sublingual) |
| Protein Binding | N/A (Degraded by proteases) |
| Half-life | Variable (Hours for proteins, weeks for immune effect) |
| Tmax | 30-60 minutes (for systemic absorption) |
| Metabolism | Local tissue proteolysis |
| Excretion | Renal (as small peptides/amino acids) |
Mucor Plumbeus extract is a complex mixture of proteins, glycoproteins, and polysaccharides. The molecular weights of the major allergens usually range from 10 to 70 kDa. It is soluble in water and saline-buffered solutions. Because it is a biological product derived from living mold cultures, the exact chemical composition can vary between batches.
Mucor Plumbeus is classified as a Non-Standardized Fungal Allergenic Extract. It shares therapeutic space with other mold extracts like Alternaria alternata and Cladosporium herbarum. It is distinct from 'Standardized' extracts which have more rigorous potency requirements.
Common questions about Mucor Plumbeus
Mucor Plumbeus is primarily used as an allergenic extract for the diagnosis and treatment of mold allergies. In a clinical setting, it is used in skin prick tests to identify if a patient is sensitive to this specific fungus. If sensitivity is confirmed, it is then used in allergen immunotherapy, commonly known as 'allergy shots.' The goal of this treatment is to desensitize the immune system to the mold over time. This helps reduce symptoms like sneezing, runny nose, and asthma that occur when the patient is exposed to environmental mold.
The most frequent side effects are local reactions at the site of the injection. These include redness, swelling, and itching where the needle entered the skin. These reactions are usually mild and disappear within 24 to 48 hours. Some patients may also experience a 'late-phase' reaction where the swelling appears several hours after the injection. While these are common, any large local reaction (bigger than the palm of your hand) should be reported to your doctor.
It is generally advised to avoid alcohol on the days you receive a Mucor Plumbeus injection. Alcohol can cause vasodilation, which is the widening of blood vessels. This can lead to faster absorption of the allergen into your bloodstream, potentially increasing the risk of a serious systemic reaction. Additionally, alcohol can mask some of the early symptoms of an allergic reaction, making it more dangerous. Always wait at least several hours after your injection before consuming any alcoholic beverages.
Mucor Plumbeus is generally not started during pregnancy because of the risk of anaphylaxis, which can be fatal to the fetus. However, if a woman is already on a stable maintenance dose and is tolerating it well, many doctors will allow her to continue the treatment. The dose is typically not increased during the pregnancy to keep the risk as low as possible. If you are planning to become pregnant or find out you are pregnant while on this treatment, you must notify your allergist immediately to discuss a safety plan.
Allergen immunotherapy is a long-term commitment and does not provide immediate relief like antihistamines do. Most patients begin to feel an improvement in their symptoms during the 'maintenance phase,' which usually starts 3 to 6 months after the beginning of treatment. Significant and lasting relief typically requires 12 months of consistent injections. Doctors usually recommend continuing the treatment for 3 to 5 years to ensure the immune system remains desensitized long after the injections stop.
Yes, you can stop taking Mucor Plumbeus injections at any time without experiencing physical withdrawal symptoms. However, stopping the treatment before the recommended 3-to-5-year course is finished usually means your allergy symptoms will eventually return. If you stop for a few weeks and then want to restart, you cannot simply take your last dose; your doctor will need to lower the dose to ensure your safety. Always talk to your allergist before deciding to discontinue your immunotherapy schedule.
If you miss a dose, you should contact your allergist's office as soon as possible to reschedule. Do not try to make up for the missed dose by taking a higher dose later. Depending on how many weeks have passed since your last injection, your doctor may need to repeat your previous dose or even reduce the dose slightly to prevent a reaction. Safety is the priority when the regular schedule is interrupted. If you miss several doses in a row, you may need to restart the build-up phase from a lower concentration.
There is no clinical evidence to suggest that Mucor Plumbeus allergenic extracts cause weight gain. Unlike oral corticosteroids, which are sometimes used to treat severe allergies and can cause weight changes, allergenic extracts work on the immune system without affecting metabolism or appetite. If you experience weight gain while on this treatment, it is likely due to other factors or medications. You should discuss any concerns about weight with your primary care physician.
Mucor Plumbeus can be taken with many other medications, but there are critical exceptions. You must avoid beta-blockers, as they make it difficult to treat a severe allergic reaction. Other medications like ACE inhibitors and certain antidepressants can also interact with how your body responds to the extract or the emergency treatments for it. Always provide your allergist with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking to ensure there are no dangerous interactions.
The concept of 'generic' is different for allergenic extracts than for standard pills. Because Mucor Plumbeus is a non-standardized biological product, extracts from different manufacturers are not considered identical or 'generic' equivalents of one another. Each manufacturer has its own proprietary method for creating the extract. Therefore, you should not switch between different brands of Mucor Plumbeus without close medical supervision, as the potency may vary significantly between them.